K070204

Substantially Equivalent

LINK TO ACUITY CLINICIAN NOTIFIER

Applicant: Welch Allyn Protocol, Inc.
Product code: MSX
Advisory panel: Cardiovascular
Date received: 2007-01-22
Decision date: 2007-03-23
Decision: Substantially Equivalent
Clearance type: Special
Location: Beaverton, OR, US

Adverse events under product code MSX

product code MSX

Death: 59
Total: 59

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.